Common Patenting Tactic by Drug Companies May Be Illegal, F.T.C. Says

The Federal Trade Commission on Thursday issued what amounted to a warning to pharmaceutical companies about the legality of a widespread patenting strategy that experts say has helped keep inhaler costs high for patients with asthma and lung problems. In a policy statement unanimously endorsed by…#ftc #linakhan
Source: Reuters: Health - Category: Consumer Health News Source Type: news